| P/E (FY) | — | Sales (TTM) | $357,870 |
| Earnings (TTM) | -$11.1M | ROE | −320.47% |
| Net Margin | −3959.40% | ROIC | — |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 44.27% |
| Market Cap | $6.8M | Trading Days | 1231 |
| 52W High | 1.89 |
| 52W Low | 0.16 |
| % Off High | −85.89% |
| YTD | −77.31% | 1Y | −83.02% |
| 3Y | −90.65% | 5Y | −98.64% |
| Since incept. (ann.) | −63.91% |
Product 83% · Royalty 17%
| Ann. Volatility (1Y) | 141.29% | Ann. Volatility (3Y) | 113.34% |
| Sharpe (1Y) | −0.58 | Sharpe (3Y) | −0.13 |
| Max Drawdown (1Y) | −90.77% | Max Drawdown (3Y) | −95.08% |
| Beta (3Y, vs SPY) | 1.32 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| MGRX | MANGOCEUTICALS, INC. | $9.5M | — |
| CCEL | CRYO CELL INTERNATIONAL INC | $27.3M | — |
| MRAI | Marpai, Inc. | $53.1M | — |
| PARK | Park Dental Partners, Inc. | $89.1M | — |
| VMD | VIEMED HEALTHCARE, INC. | $457.0M | 32.2 |
| PGNY | Progyny, Inc. | $2.41B | 47.3 |
| SHC | Sotera Health Co | $5.06B | 65.8 |
| DVA | DAVITA INC. | $15.37B | 24.3 |
| AGL | agilon health, inc. | $41.04B | — |
| FMS | Fresenius Medical Care AG | — | — |
| SINT | Sintx Technologies, Inc. | $6.7M | — |
| NXL |
| Nexalin Technology, Inc. |
| $6.9M |
| — |
